Search

Your search keyword '"Eller, K."' showing total 348 results
Start Over Author "Eller, K."
348 results on '"Eller, K."'

2. AB1202 SUCCESSFUL LONG-TERM TREATMENT OF SYSTEMIC SCLEROSIS BY HIGH-FREQUENT, LOW-DOSE B CELL DEPLETING THERAPY

Author

Moazedi-Fuerst, F., primary, Lackner, A., additional, Kreuzer, S., additional, Eller, K., additional, Kovacs, G., additional, Flick, H., additional, Balazs, O., additional, Talakic, E., additional, Hermann, J., additional, Venhoff, N., additional, Venhoff, A., additional, Jud, P., additional, Yazdani-Biuki, B., additional, Brodmann, M., additional, Salmhofer, W., additional, Husic, R., additional, Stradner, M., additional, Graninger, W., additional, Thiel, J., additional, and Brezinsek, H. P., additional

Published
2024
Full Text
View/download PDF

3. Identification and quantification of flavonoids and hydroxycinnamic acids in yellow wood anemone (Anemone ranunculoides L.) by UHPLC-DAD-HESI/MS analysis

Author

Luferov, A. N., primary, Bobkova, N. V., additional, Bokov, D. O., additional, Rodin, M. N., additional, Sergunova, E. V., additional, Kovaleva, T. Yu., additional, Rendyuk, T. D., additional, Strelyaeva, A. V., additional, Antsyshkina, A. M., additional, Prostodusheva, T. V., additional, Zaichikova, S. G., additional, Baeva, V. M., additional, Perova, I. B., additional, Eller, K. I., additional, and Bessonov, V. V., additional

Published
2024
Full Text
View/download PDF

9. Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions

Author

Sharif, A., Hecking, M., de Vries, A.P.J., Porrini, E., Hornum, M., Rasoul-Rockenschaub, S., Berlakovich, G., Krebs, M., Kautzky-Willer, A., Schernthaner, G., Marchetti, P., Pacini, G., Ojo, A., Takahara, S., Larsen, J.L., Budde, K., Eller, K., Pascual, J., Jardine, A., Bakker, S.J.L., Valderhaug, T.G., Jenssen, T.G., Cohney, S., and Säemann, M.D.

Published
2014
Full Text
View/download PDF

11. TTV GUIDE IT - A randomised controlled trial to compare the safety, tolerability and preliminary efficacy between standard and torque teno virus-guided immunosuppression in stable adult kidney transplant recipients with low immunological risk in the first year after transplantation - a trial protocol

Author

Haupenthal, F., Neuwirt, H., Eller, K., Cejka, D., Banas, B., Budde, K., Rotmans, J., Rostaing, L., Malvezzi, P., Bakker, S., Viklicky, O., Beneyto, I., Ohlmann, S., Bourgeois, P., Del Alamo, M., Navarro, D., Rodriguez-Arias, D., Maggi, F., Grahlert, X., Puchhammer-Stockl, E., Regele, H., Vossen, M., Bohmig, G., Wolzt, M., Jilma, B., Herkner, H., Konig, F., Hugo, C., and Bond, G.

Published
2021

12. Rituximab in Membranous Nephropathy

Author

Gauckler, P., Shin, J.I., Alberici, F., Audard, V., Bruchfeld, A., Busch, M., Cheung, C.K., Crnogorac, M., Delbarba, E., Eller, K., Faguer, S., Galesic, K., Griffin, Sian, Hoogen, M.W.F. van den, Hrušková, Z., Jeyabalan, A., Karras, A., King, C., Kohli, H.S., Mayer, G., Maas, R.J.H., Muto, M., Moiseev, S., Odler, B., Pepper, R.J., Quintana, L.F., Radhakrishnan, J., Ramachandran, R., Salama, A.D., Schönermarck, U., Segelmark, M., Smith, L., Tesař, V., Wetzels, J., Willcocks, L., Windpessl, M., Zand, L., Zonozi, R., Kronbichler, A., Gauckler, P., Shin, J.I., Alberici, F., Audard, V., Bruchfeld, A., Busch, M., Cheung, C.K., Crnogorac, M., Delbarba, E., Eller, K., Faguer, S., Galesic, K., Griffin, Sian, Hoogen, M.W.F. van den, Hrušková, Z., Jeyabalan, A., Karras, A., King, C., Kohli, H.S., Mayer, G., Maas, R.J.H., Muto, M., Moiseev, S., Odler, B., Pepper, R.J., Quintana, L.F., Radhakrishnan, J., Ramachandran, R., Salama, A.D., Schönermarck, U., Segelmark, M., Smith, L., Tesař, V., Wetzels, J., Willcocks, L., Windpessl, M., Zand, L., Zonozi, R., and Kronbichler, A.

Abstract

Contains fulltext : 245229.pdf (Publisher’s version ) (Open Access), Membranous nephropathy (MN) is the most common cause of primary nephrotic syndrome among adults. The identification of phospholipase A2 receptor (PLA2R) as target antigen in most patients changed the management of MN dramatically, and provided a rationale for B-cell depleting agents such as rituximab. The efficacy of rituximab in inducing remission has been investigated in several studies, including 3 randomized controlled trials, in which complete and partial remission of proteinuria was achieved in approximately two-thirds of treated patients. Due to its favorable safety profile, rituximab is now considered a first-line treatment option for MN, especially in patients at moderate and high risk of deterioration in kidney function. However, questions remain about how to best use rituximab, including the optimal dosing regimen, a potential need for maintenance therapy, and assessment of long-term safety and efficacy outcomes. In this review, we provide an overview of the current literature and discuss both strengths and limitations of "the new standard."

Published
2021

21. Kardiovaskuläre Komplikationen des sekundären Hyperparathyreoidismus bei Patienten mit chronischer Niereninsuffizienz

Author

Eller K

Subjects
aktives Vitamin D, Kalzium, kardiovaskuläre Verkalkung, Phosphatbinder, lcsh:R, lcsh:Medicine, Kalzimimetika, Phosphat, sekundärer Hyperparathyreoidismus
Abstract

Die kardiovaskuläre Mortalität von chronisch niereninsuffizienten (CKD-) Patienten ist signifikant erhöht im Vergleich zur Allgemeinbevölkerung. Experimentelle In-vitro- und In-vivo-Studien sowie Observationsdaten zeigen, dass der sekundäre Hyperparathyreoidismus (sHPT) und die damit verbundenen Entgleisungen des Kalzium-Phosphat-Haushalts wesentliche Faktoren in der Pathogenese der kardiovaskulären Verkalkung bei CKD-Patienten sind. Medikamentös stehen uns in der Therapie des sHPT Phosphatbinder, aktive Vitamin-D-Präparate und Kalzimimetika zur Verfügung. Kalziumfreie Phosphatbinder wie Sevelamer können die kardiovaskuläre Verkalkung reduzieren, wohingegen kalziumhältige diese verschlechtern. Ob Sevelamer auch die kardiovaskuläre Mortalität bei CKD-Patienten verbessern kann, ist immer noch unklar. Aktive Vitamin-D-Präparate führen experimentell zu einer Verschlechterung der kardiovaskulären Verkalkung. Im Gegensatz dazu besitzt das Vitamin-D-Analogon Paricalcitol diese Eigenschaften experimentell nicht. Ob es allerdings auch in CKD-Patienten zu einer Verbesserung der kardiovaskulären Mortalität führt, ist umstritten. Das Kalzimimetikum Cinacalcet konnte in experimentellen Studien die Verkalkungsprozesse limitieren. In der ADVANCE-Studie konnte eine Reduktion der Verkalkungsprozesse in CKD-Patienten durch Cinacalcet nachgewiesen werden, allerdings konnte eine Signifikanz nur im Bereich der Aortenklappenverkalkung erreicht werden. Rezent wurde die EVOLVE-Studie zur Evaluation der kardiovaskulären Mortalität bei CKD-Patienten an der Hämodialyse unter Kalzimimetika-Therapie publiziert. Allerdings konnte in der Intention-to-Treat-Analyse kein Benefit hinsichtlich der kardiovaskulären Ereignisse in der Cinacalcet-Gruppe gezeigt werden. Erst in Post-hoc-Analysen fand sich ein Benefit. Zusammenfassend spielt der sHPT in der Pathogenese der kardiovaskulären Verkalkung bei CKD-Patienten eine entscheidende Rolle, allerdings benötigen wir nach wie vor Studien, die die perfekte Kombinationstherapie zur Senkung der kardiovaskulären Mortalität nachweisen.

Published
2014

22. Serum iron level and kidney function: a Mendelian randomization study

Author

Del Greco M, F, Foco, L, Pichler, I, Eller, P, Eller, K, Benyamin, B, Whitfield, JB, Genetics of Iron Status Consortium, CKDGen Consortium, Pramstaller, PP, Thompson, JR, Pattaro, C, Minelli, C, Del Greco, Fabiola M, Foco, Luisa, Pichler, Irene, Eller, Philipp, Eller, Kathrin, Benyamin, Beben, Whitfield, John B, Pramstaller, Peter P, Thompson, John R, Pattaro, Cristian, Minelli, Cosetta, Genetics Iron Status Consortium, and CKDGen Consortium

Subjects
0301 basic medicine, medicine.medical_specialty, Iron, Population, 030232 urology & nephrology, Renal function, 03 medical and health sciences, 0302 clinical medicine, iron, Risk Factors, Internal medicine, Mendelian randomization, medicine, Humans, Genetic Predisposition to Disease, Renal Insufficiency, Chronic, education, kidney function, Transplantation, education.field_of_study, glomerular filtration rate, biology, medicine.diagnostic_test, business.industry, Confounding, ferritin, 1103 Clinical Sciences, Urology & Nephrology, Mendelian Randomization Analysis, medicine.disease, Confidence interval, Ferritin, 030104 developmental biology, Endocrinology, Nephrology, biology.protein, Serum iron, business, chronic kidney disease, Kidney disease, Glomerular Filtration Rate
Abstract

Background: Iron depletion is a known consequence of chronic kidney disease (CKD), but there is contradicting epidemiological evidence on whether iron itself affects kidney function and whether its effect is protective or detrimental in the general population. While epidemiological studies tend to be affected by confounding and reverse causation, Mendelian randomization (MR) can provide unconfounded estimates of causal effects by using genes as instruments. Methods: We performed an MR study of the effect of serum iron levels on estimated glomerular filtration rate (EGFR), using genetic variants known to be associated with iron.MR estimates of the effect of iron on EGFR were derived based on the association of each variant with iron and EGFR from two large genome-wide meta-analyses on 48 978 and 74 354 individuals. We performed a similar MR analysis for ferritin, which measures iron stored in the body, using variants associated with ferritin. Results: A combined MR estimate across all variants showed a 1.3% increase in EGFR per standard deviation increase in iron (95% confidence interval 0.4-2.1%; P = 0.004). The results for ferritin were consistent with those for iron. Secondary MR analyses of the effects of iron and ferritin on CKD did not show significant associations but had very low statistical power. Conclusions: Our study suggests a protective effect of iron on kidney function in the general population. Further research is required to confirm this causal association, investigate it in study populations at higher risk of CKD and explore its underlyingmechanismof action. Refereed/Peer-reviewed

Published
2016

23. Hypokalziämie und Hyperkalziämie: Ätiologie, Klinik, Diagnose und Therapie

Author

Eller K

Subjects
Endokrinologie, lcsh:RC648-665, Diagnose, Klinik, Therapie, lcsh:Diseases of the endocrine glands. Clinical endocrinology
Abstract

Kalzium liegt im Blut nur zu 40 % in ionisierter Form vor, wohingegen 45 % an Albumin und 15 % an kleine Anionen gebunden sind. Daher ist eine Bestimmung der Serum-Albuminkonzentration sowie des ionisierten Kalziums für die weitere Diagnostik und Therapie bei Patienten mit Hypo- und Hyperkalziämie entscheidend. Pathologien des Kalziumhaushaltes sind meist durch Störungen in der Kalziumhomöostase bedingt. Hier spielen die Hormone Parathormon und Calcitonin sowie das Vitamin D und seine Metaboliten eine entscheidende Rolle. Im Weiteren werden die Ätiologie, Klinik, Diagnose und Therapie sowohl der Hypo- als auch der Hyperkalziämie abgehandelt.

Published
2011

24. Sonographische Verlaufskontrollen der Hüftdysplasie unter Spreizhosentherapie

Author

Eller K and Katthagen Bd

Subjects
medicine.medical_specialty, Type iib, business.industry, Ultrasound screening, Ultrasound, Femoral head necrosis, Medicine, Orthopedics and Sports Medicine, Surgery, Ultrasonography, business
Abstract

121 children with cdh, which haven been treated between June 84 and December 85 in our out-patient-ward with Aktivspreizhose (abduction-pants), have been followed by ultrasound examination. Reliability of hip ultrasonography, duration of treatment and results have been evaluated. At the beginning of treatment the diagnosis were: 24.8% type IIa, 29.6% type IIb, 13.2% type IIG or IID and 5.8% type IIIa according to Graf; in 6.6% of the cases cdh was diagnosed only by x-rays. Hip ultrasonography was highly reliable according to quality controls in comparison to x-rays and short-ended the duration of treatment. With the exception of 3 children (1 Myelodysplasia, 2 start of treatment after the 6 months of life) all children with "Aktivspreizhose" treatment showed anatomic healing. Duration of treatment was 4.2 months on the average, 3.5 months when treatment started in the first 3 months of life, and 4.7 months, when started after the first 3 months of life. X-ray-controls at the end of treatment showed mild forms of femoral head necrosis (type I and II) in two cases, which healed completely according to follow up controls. For the treatment of cdh in babies the Aktivspreizhose is the optimal therapy, especially when started in the first 3 months of life. A general legal orthopaedic clinical and ultrasound screening of babies hip in the first week of life should be introduced.

Published
2008

25. P1582Dietary spermidine ameliorates hypertension and prevents diastolic dysfunction in Dahl salt-sensitive rats

Author

Abdellatif, M., primary, Eisenberg, T., additional, Primessnig, U., additional, Pendl, T., additional, Magnes, C., additional, Herbst, V., additional, Von Frieling-Salewsky, M., additional, Kirsch, A., additional, Meinitzer, A., additional, Eller, K., additional, Linke, W.A., additional, Kiechl, S., additional, Kroemer, G., additional, Madeo, F., additional, and Sedej, S., additional

Published
2017
Full Text
View/download PDF

27. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry

Author

Hruskova, Z., Stel, V.S., Jayne, D., Aasarod, K., Meester, J. de, Ekstrand, A., Eller, K., Heaf, J.G., Hoitsma, A.J., Jimenez, C. Martos, Ravani, P., Wanner, C., Tesar, V., Jager, K.J., Hruskova, Z., Stel, V.S., Jayne, D., Aasarod, K., Meester, J. de, Ekstrand, A., Eller, K., Heaf, J.G., Hoitsma, A.J., Jimenez, C. Martos, Ravani, P., Wanner, C., Tesar, V., and Jager, K.J.

Abstract

Item does not contain fulltext, BACKGROUND: This study describes the incidence and outcomes of European patients requiring renal replacement therapy (RRT) for kidney failure due to antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). STUDY DESIGN: Cohort study. SETTING & PARTICIPANTS: 12 renal registries providing individual RRT patient data to the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry in 1993-2012 participated. PREDICTOR: Cause of primary kidney disease: AAV (ie, granulomatosis with polyangiitis [Wegener] and microscopic polyangiitis) versus 3 separate matched control groups without AAV: (1) primary glomerulonephritis, (2) diabetes mellitus, and (3) disease other than diabetes mellitus as the cause of primary kidney disease, including glomerulonephritis (termed "nondiabetes"). OUTCOMES: Incidence, causes of death, and survival. MEASUREMENTS: ERA-EDTA primary renal disease codes. RESULTS: 2,511 patients with AAV (1,755, granulomatosis with polyangiitis; 756, microscopic polyangiitis) were identified, representing an incidence of 1.05 per million population (pmp) for granulomatosis with polyangiitis (predominating in Northern Europe) and 0.45 pmp for microscopic polyangiitis (prevailing in Southern Europe). Kidney transplantation was performed in 558 (22.2%) patients with vasculitis. The 10-year probability for survival on RRT after day 91 was 32.5% (95% CI, 29.9%-35.1%) in patients with vasculitis. Survival on RRT after day 91 did not differ between AAV and matched nondiabetes patients. Patient and transplant survival after kidney transplantation, adjusted for time period and country, was better in AAV than in matched nondiabetes patients (HRs of 0.81 [95% CI, 0.67-0.99] and 0.82 [95% CI, 0.69-0.96], respectively). LIMITATIONS: No data for extrarenal manifestations, treatment, and relapses. CONCLUSIONS: Geographical differences in the incidence of RRT for kidney failure due to granulomatosis with polyangiitis and microscopic

Published
2015

32. PATHOLOGY INFLAMMATION

Author

Maciel, T. T., primary, Merle, E., additional, Fricot, A., additional, Monteiro, R., additional, Moura, I. C., additional, Seleznik, G., additional, Seeger, H., additional, Papandile, A., additional, Fu, K., additional, Poreci, U., additional, Czerkowicz, J., additional, Rabah, D., additional, Ranger, A., additional, Cohen, C. D., additional, Lindenmeyer, M., additional, Chen, J., additional, Edenhofer, I., additional, Anders, H.-J., additional, Lech, M., additional, Wuthrich, R. P., additional, Ruddle, N. H., additional, Moeller, M. J., additional, Regele, H., additional, Kozakowski, N., additional, Bauer, J., additional, Heikenwalder, M., additional, Browning, J. L., additional, Segerer, S., additional, Kirsch, A. H., additional, Artinger, K., additional, Rho, E., additional, Wolf, A. M., additional, Cornez, I., additional, Eller, P., additional, Wolf, D., additional, Rosenkranz, A. R., additional, Eller, K., additional, Schaubettl, C., additional, Aringer, I., additional, Grande, J. P., additional, Hartono, S. P., additional, Kashyap, S., additional, and Knudsen, B., additional

Published
2014
Full Text
View/download PDF

33. PATHOLOGY: IMMUNE AND INFLAMMATORY MECHANISMS

Author

Kozakowski, N., primary, Herkner, H., additional, Bohmig, G. A., additional, Kikic, Z., additional, Cooper, D. J., additional, Eller, K., additional, Kirsch, A. H., additional, Lane, P. J., additional, Neirynck, N., additional, Glorieux, G., additional, Schepers, E., additional, Dhondt, A., additional, Vanholder, R., additional, Corradetti, V., additional, Milanesi, S., additional, Rocca, C., additional, Avanzini, M. A., additional, Pattonieri, E. F., additional, Bosio, F., additional, Cannone, M., additional, Maggi, N., additional, Gregorini, M., additional, Esposito, P., additional, Rampino, T., additional, Dal Canton, A., additional, Roelofs, J. J., additional, Redecha, P., additional, Salmon, J. E., additional, Rho, E., additional, Artinger, K., additional, Schaubettl, C., additional, Aringer, I., additional, Rosenkranz, A. R., additional, Eller, P., additional, Perri, A., additional, Vizza, D., additional, Toteda, G., additional, Lupinacci, S., additional, Lofaro, D., additional, Leone, F., additional, Gigliotti, P., additional, La Russa, A., additional, Papalia, T., additional, Bonofilgio, R., additional, and Schabhuttl, C., additional

Published
2014
Full Text
View/download PDF

35. Immune and inflammatory mechanisms

Author

Castellano, G., primary, Cafiero, C., additional, Divella, C., additional, Sallustio, F., additional, Gigante, M., additional, Gesualdo, L., additional, Kirsch, A. H., additional, Smaczny, N., additional, Riegelbauer, V., additional, Sedej, S., additional, Hofmeister, A., additional, Stojakovic, T., additional, Brodmann, M., additional, Pilger, E., additional, Rosenkranz, A., additional, Eller, K., additional, Eller, P., additional, Meier, P., additional, Lucisano, S., additional, Arena, A., additional, Donato, V., additional, Fazio, M. R., additional, Santoro, D., additional, Buemi, M., additional, Wornle, M., additional, Ribeiro, A., additional, Koppel, S., additional, Pircher, J., additional, Czermak, T., additional, Merkle, M., additional, Rupanagudi, K., additional, Kulkarni, O. P., additional, Lichtnekert, J., additional, Darisipudi, M. N., additional, Mulay, S. R., additional, Schott, B., additional, Hartmann, G., additional, Anders, H.-J., additional, Pletinck, A., additional, Glorieux, G., additional, Schepers, E., additional, Van Landschoot, M., additional, Eloot, S., additional, Van Biesen, W., additional, Vanholder, R., additional, Castoldi, A., additional, Oliveira, V., additional, Amano, M., additional, Aguiar, C., additional, Caricilli, A., additional, Vieira, P., additional, Burgos, M., additional, Hiyane, M., additional, Festuccia, W., additional, Camara, N., additional, Djudjaj, S., additional, Rong, S., additional, Lue, H., additional, Bajpai, A., additional, Klinkhammer, B., additional, Moeller, M., additional, Floege, J., additional, Bernhagen, J., additional, Ostendorf, T., additional, Boor, P., additional, Ito, S., additional, Aoki, R., additional, Hamada, K., additional, Edamatsu, T., additional, Itoh, Y., additional, Osaka, M., additional, Yoshida, M., additional, Oliva, E., additional, Maritati, F., additional, Palmisano, A., additional, Alberici, F., additional, Buzio, C., additional, Vaglio, A., additional, Grabulosa, C., additional, Cruz, E., additional, Carvalho, J., additional, Manfredi, S., additional, Canziani, M., additional, Cuppari, L., additional, Quinto, B., additional, Batista, M., additional, Cendoroglo, M., additional, Dalboni, M., additional, Niemir, Z., additional, Swierzko, A., additional, Polcyn-Adamczak, M., additional, Cedzynski, M., additional, Sokolowska, A., additional, Szala, A., additional, Baudoux, T., additional, Hougardy, J.-M., additional, Pozdzik, A., additional, Antoine, M.-H., additional, Husson, C., additional, De Prez, E., additional, Nortier, J., additional, Ni, H.-F., additional, Chen, J.-F., additional, Zhang, M.-H., additional, Pan, M.-M., additional, Liu, B.-C., additional, Machcinska, M., additional, Bocian, K., additional, Korczak-Kowalska, G., additional, Tami Amano, M., additional, Andrade-Oliveira, V., additional, da Silva, M., additional, Miyagi, M. Y. S., additional, Olsen Camara, N., additional, Xu, L., additional, Jin, Y., additional, Zhong, F., additional, Liu, J., additional, Dai, Q., additional, Wang, W., additional, Chen, N., additional, Grosjean, F., additional, Tribioli, C., additional, Esposito, V., additional, Catucci, D., additional, Azar, G., additional, Torreggiani, M., additional, Merlini, G., additional, Esposito, C., additional, Fell, L. H., additional, Zawada, A. M., additional, Rogacev, K. S., additional, Seiler, S., additional, Fliser, D., additional, Heine, G. H., additional, Neprintseva, N., additional, Tchebotareva, N., additional, Bobkova, I., additional, Kozlovskaya, L., additional, Virzi, G. M., additional, Brocca, A., additional, de Cal, M., additional, Bolin, C., additional, Vescovo, G., additional, Ronco, C., additional, Fuchs, A., additional, Eidenschink, K., additional, Steege, A., additional, Fellner, C., additional, Bollheimer, C., additional, Gronwald, W., additional, Schroeder, J., additional, Banas, B., additional, Banas, M. C., additional, Luthe, A., additional, Seiler, S. S., additional, Rogacev, K., additional, Trimboli, D., additional, Graziani, G., additional, Haroche, J., additional, Lupica, R., additional, Cernaro, V., additional, Montalto, G., additional, Pettinato, G., additional, Cho, E., additional, Lee, J.-W., additional, Kim, M.-G., additional, Jo, S.-K., additional, Cho, W.-Y., additional, and kim, H.-K., additional

Published
2013
Full Text
View/download PDF

39. Experimental pathology

Author

Yi Chun, D. X., primary, Alexandre, H., additional, Edith, B., additional, Nacera, O., additional, Julie, P., additional, Chantal, J., additional, Eric, R., additional, Zhang, X., additional, Jin, Y., additional, Miravete, M., additional, Dissard, R., additional, Klein, J., additional, Gonzalez, J., additional, Caubet, C., additional, Pecher, C., additional, Pipy, B., additional, Bascands, J.-L., additional, Mercier-Bonin, M., additional, Schanstra, J., additional, Buffin-Meyer, B., additional, Claire, R., additional, Rigothier, C., additional, Richard, D., additional, Sebastien, L., additional, Moin, S., additional, Chantal, B., additional, Christian, C., additional, Jean, R., additional, Migliori, M., additional, Cantaluppi, V., additional, Mannari, C., additional, Medica, D., additional, Giovannini, L., additional, Panichi, V., additional, Goldwich, A., additional, Alexander, S., additional, Andre, G., additional, Amann, K., additional, Migliorini, A., additional, Sagrinati, C., additional, Angelotti, M. L., additional, Mulay, S. R., additional, Ronconi, E., additional, Peired, A., additional, Romagnani, P., additional, Anders, H.-J., additional, Chiang, W. C., additional, Lai, C. F., additional, Peng, W.-H., additional, Wu, C. F., additional, Chang, F.-C., additional, Chen, Y.-T., additional, Lin, S.-L., additional, Chen, Y. M., additional, Wu, K. D., additional, Lu, K.-S., additional, Tsai, T. J., additional, Virgine, O., additional, Qing Feng, F., additional, Zhang, S.-Y., additional, Dominique, D., additional, Vincent, A., additional, Marina, C., additional, Philippe, L., additional, Georges, G., additional, Pawlak, A., additional, Sahali, D., additional, Matsumoto, S., additional, Kiyomoto, H., additional, Ichimura, A., additional, Dan, T., additional, Nakamichi, T., additional, Tsujita, T., additional, Akahori, K., additional, Ito, S., additional, Miyata, T., additional, Xie, S., additional, Zhang, B., additional, Shi, W., additional, Yang, Y., additional, Nagasu, H., additional, Satoh, M., additional, Kidokoro, K., additional, Nishi, Y., additional, Ihoriya, C., additional, Kadoya, H., additional, Sasaki, T., additional, Kashihara, N., additional, Wu, C.-F., additional, Chou, Y.-H., additional, Duffield, J., additional, Rocca, C., additional, Gregorini, M., additional, Corradetti, V., additional, Valsania, T., additional, Bedino, G., additional, Bosio, F., additional, Pattonieri, E. F., additional, Esposito, P., additional, Sepe, V., additional, Libetta, C., additional, Rampino, T., additional, Dal Canton, A., additional, Omori, H., additional, Kawada, N., additional, Inoue, K., additional, Ueda, Y., additional, Yamamoto, R., additional, Matsui, I., additional, Kaimori, J., additional, Takabatake, Y., additional, Moriyama, T., additional, Isaka, Y., additional, Rakugi, H., additional, Wasilewska, A., additional, Taranta-Janusz, K., additional, Deebek, W., additional, Kuroczycka-Saniutycz, E., additional, Lee, A. S., additional, Lee, J. E., additional, Jung, Y. J., additional, Kang, K. P., additional, Lee, S., additional, Kim, W., additional, Arfian, N., additional, Emoto, N., additional, Yagi, K., additional, Nakayama, K., additional, Hartopo, A. B., additional, Nugrahaningsih, D. A., additional, Yanagisawa, M., additional, Hirata, K.-I., additional, Munoz-Felix, J. M., additional, Lopez-Novoa, J. M., additional, Martinez-Salgado, C., additional, Oujo, B., additional, Arevalo, M., additional, Bernabeu, C., additional, Perez-Barriocanal, F., additional, Jesper, K., additional, Nathalie, V., additional, Pierre, G., additional, Yi Chun, D. X., additional, Iyoda, M., additional, Shibata, T., additional, Matsumoto, K., additional, Shindo-Hirai, Y., additional, Kuno, Y., additional, Wada, Y., additional, Akizawa, T., additional, Schwartz, I., additional, Schwartz, D., additional, Prot Bertoye, C., additional, Terryn, S., additional, Claver, J., additional, Beghdadi, W. B., additional, Monteiro, R., additional, Blank, U., additional, Devuyst, O., additional, Daugas, E., additional, Van Beneden, K., additional, Geers, C., additional, Pauwels, M., additional, Mannaerts, I., additional, Van den Branden, C., additional, Van Grunsven, L. A., additional, Seckin, I., additional, Pekpak, M., additional, Uzunalan, M., additional, Uruluer, B., additional, Kokturk, S., additional, Ozturk, Z., additional, Sonmez, H., additional, Yaprak, E., additional, Furuno, Y., additional, Tsutsui, M., additional, Morishita, T., additional, Shimokawa, H., additional, Otsuji, Y., additional, Yanagihara, N., additional, Kabashima, N., additional, Ryota, S., additional, Kanegae, K., additional, Miyamoto, T., additional, Nakamata, J., additional, Ishimatsu, N., additional, Tamura, M., additional, Nakagawa, T., additional, Ichikawa, K., additional, Miyamoto, M., additional, Takabayashi, D., additional, Yamazaki, H., additional, Kakeshita, K., additional, Koike, T., additional, Kagitani, S., additional, Tomoda, F., additional, Hamashima, T., additional, Ishii, Y., additional, Inoue, H., additional, Sasahara, M., additional, El Machhour, F., additional, Kerroch, M., additional, Mesnard, L., additional, Chatziantoniou, C., additional, Dussaule, J.-C., additional, Inui, K., additional, Sasai, F., additional, Maruta, Y., additional, Nishiwaki, H., additional, Kawashima, E., additional, Inoue, Y., additional, Yoshimura, A., additional, Musacchio, E., additional, Priante, G., additional, Valvason, C., additional, Sartori, L., additional, Baggio, B., additional, Kim, J. H., additional, Gross, O., additional, Diana, R., additional, Gry, D. H., additional, Asimal, B., additional, Johanna, T., additional, Imke, S.-E., additional, Lydia, W., additional, Gerhard-Anton, M., additional, Hassan, D., additional, Cano, J. L., additional, Griera, M., additional, Olmos, G., additional, Martin, P., additional, Cortes, M. A., additional, Lopez-Ongil, S., additional, Rodriguez-Puyol, D., additional, DE Frutos, S., additional, Gonzalez, M., additional, Luengo, A., additional, Rodriguez-Puyol, M., additional, Calleros, L., additional, Lupica, R., additional, Lacquaniti, A., additional, Donato, V., additional, Maggio, R., additional, Mastroeni, C., additional, Lucisano, S., additional, Cernaro, V., additional, Fazio, M. R., additional, Quartarone, A., additional, Buemi, M., additional, Kacik, M., additional, Goedicke, S., additional, Eggert, H., additional, Hoyer, J. D., additional, Wurm, S., additional, Steege, A., additional, Banas, M., additional, Kurtz, A., additional, Banas, B., additional, Lasagni, L., additional, Lazzeri, E., additional, Romoli, S., additional, Schaefer, I., additional, Teng, B., additional, Worthmann, K., additional, Haller, H., additional, Schiffer, M., additional, Prattichizzo, C., additional, Netti, G. S., additional, Rocchetti, M. T., additional, Cormio, L., additional, Carrieri, G., additional, Stallone, G., additional, Grandaliano, G., additional, Ranieri, E., additional, Gesualdo, L., additional, Kucher, A., additional, Smirnov, A., additional, Parastayeva, M., additional, Beresneva, O., additional, Kayukov, I., additional, Zubina, I., additional, Ivanova, G., additional, Abed, A., additional, Schlekenbach, L., additional, Foglia, B., additional, Kwak, B., additional, Chadjichristos, C., additional, Queisser, N., additional, Schupp, N., additional, Brand, S., additional, Himer, L., additional, Szebeni, B., additional, Sziksz, E., additional, Saijo, S., additional, Kis, E., additional, Prokai, A., additional, Banki, N. F., additional, Fekete, A., additional, Tulassay, T., additional, Vannay, A., additional, Hegner, B., additional, Schaub, T., additional, Lange, C., additional, Dragun, D., additional, Klinkhammer, B. M., additional, Rafael, K., additional, Monika, M., additional, Anna, M., additional, Van Roeyen, C., additional, Boor, P., additional, Eva Bettina, B., additional, Simon, O., additional, Esther, S., additional, Floege, J., additional, Kunter, U., additional, Janke, D., additional, Jankowski, J., additional, Hayashi, M., additional, Takamatsu, I., additional, Horimai, C., additional, Yoshida, T., additional, Seno DI Marco, G., additional, Koenig, M., additional, Stock, C., additional, Reiermann, S., additional, Amler, S., additional, Koehler, G., additional, Fobker, M., additional, Buck, F., additional, Pavenstaedt, H., additional, Lang, D., additional, Brand, M., additional, Plotnikov, E., additional, Morosanova, M., additional, Pevzner, I., additional, Zorova, L., additional, Pulkova, N., additional, Zorov, D., additional, Wornle, M., additional, Ribeiro, A., additional, Belling, F., additional, Merkle, M., additional, Nakazawa, D., additional, Nishio, S., additional, Shibasaki, S., additional, Tomaru, U., additional, Akihiro, I., additional, Kobayashi, I., additional, Imanishi, Y., additional, Kurajoh, M., additional, Nagata, Y., additional, Yamagata, M., additional, Emoto, M., additional, Michigami, T., additional, Ishimura, E., additional, Inaba, M., additional, Wu, C.-C., additional, Lu, K.-C., additional, Chen, J.-S., additional, Chu, P., additional, Lin, Y.-F., additional, Eller, K., additional, Schroll, A., additional, Kirsch, A., additional, Huber, J., additional, Weiss, G., additional, Theurl, I., additional, Rosenkranz, A. R., additional, Zawada, A., additional, Rogacev, K., additional, Achenbach, M., additional, Fliser, D., additional, Held, G., additional, Heine, G. H., additional, Miyamoto, Y., additional, Iwao, Y., additional, Watanabe, H., additional, Kadowaki, D., additional, Ishima, Y., additional, Chuang, V. T. G., additional, Sato, K., additional, Otagiri, M., additional, Maruyama, T., additional, Iwatani, H., additional, Honda, D., additional, Noguchi, T., additional, Tanaka, M., additional, Tanaka, H., additional, Fukagawa, M., additional, Pircher, J., additional, Koppel, S., additional, Mannell, H., additional, Krotz, F., additional, Virzi, G. M., additional, Bolin, C., additional, Cruz, D., additional, Scalzotto, E., additional, De Cal, M., additional, Vescovo, G., additional, Ronco, C., additional, Grobmayr, R., additional, Lech, M., additional, Ryu, M., additional, Aoshima, Y., additional, Mizobuchi, M., additional, Ogata, H., additional, Kumata, C., additional, Nakazawa, A., additional, Kondo, F., additional, Ono, N., additional, Koiwa, F., additional, Kinugasa, E., additional, Freisinger, W., additional, Lale, N., additional, Lampert, A., additional, Ditting, T., additional, Heinlein, S., additional, Schmieder, R. E., additional, Veelken, R., additional, Nave, H., additional, Perthel, R., additional, Suntharalingam, M., additional, Bode-Boger, S., additional, Beutel, G., additional, Kielstein, J., additional, Rodrigues-Diez, R., additional, Rayego-Mateos, S., additional, Lavoz, C., additional, Stark Aroeira, L. G., additional, Orejudo, M., additional, Alique, M., additional, Ortiz, A., additional, Egido, J., additional, Ruiz-Ortega, M., additional, Oskar, W., additional, Rusan, C., additional, Padberg, J.-S., additional, Wiesinger, A., additional, Reuter, S., additional, Grabner, A., additional, Kentrup, D., additional, Lukasz, A., additional, Oberleithner, H., additional, Pavenstadt, H., additional, Kumpers, P., additional, Eberhardt, H. U., additional, Skerka, C., additional, Chen, Q., additional, Hallstroem, T., additional, Hartmann, A., additional, Kemper, M. J., additional, Zipfel, P. F., additional, N'gome-Sendeyo, K., additional, Fan, Q.-F., additional, Toblli, J., additional, Cao, G., additional, Giani, J. F., additional, Dominici, F. P., additional, Kim, J. S., additional, Yang, J. W., additional, Kim, M. K., additional, Han, B. G., additional, and Choi, S. O., additional

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results